Our study, demonstrating that CXCL12 secreted by stromal cells activates invasiveness of adjacent cancer cells, suggests that this chemokine triggers mobilization of cells from the primary tumor and provides an alternative explanation to antimetastatic effects of CXCL12 blockade. This evidence concerns the gene CXCL12 and neoplasm.